These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24619317)

  • 1. To test or not to test, that is the question.
    Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):207-8. PubMed ID: 24619317
    [No Abstract]   [Full Text] [Related]  

  • 2. [When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention].
    Thomas HP; Kassner U; Steinhagen-Thiessen E
    MMW Fortschr Med; 2000 Jul; 142(30):33-4. PubMed ID: 10955017
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    McDiarmid TD; Hensel WA
    JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952195
    [No Abstract]   [Full Text] [Related]  

  • 4. Pravastatin and coronary heart disease.
    Bloom JM
    N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract]   [Full Text] [Related]  

  • 5. Using cost-effectiveness to target cholesterol reduction.
    Beaird J
    Ann Intern Med; 2001 Aug; 135(4):299-300. PubMed ID: 11511147
    [No Abstract]   [Full Text] [Related]  

  • 6. Healing unhealthy Hungarian hearts--at what cost?--With what benefit?
    Szucs TD
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):239-43. PubMed ID: 17019538
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic aspects of hypercholesterolemia treatment with HMG-CoA reductase inhibitors: a review of recent developments.
    MacNeil P
    Can J Cardiol; 1998 Apr; 14 Suppl A():14A-16A. PubMed ID: 9594928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating economic analysis into clinical trials.
    Imai K; Zhang P
    Lancet; 2005 May 21-27; 365(9473):1749-50. PubMed ID: 15910936
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness analyses.
    Clark CM
    Ann Intern Med; 2001 Sep; 135(5):382-3. PubMed ID: 11529708
    [No Abstract]   [Full Text] [Related]  

  • 10. [Titles are power--the professors do not wish to discuss statins].
    Ahnfeldt-Mollerup I; Heebøll-Nielsen NC
    Ugeskr Laeger; 1998 Sep; 160(39):5680-2. PubMed ID: 9771073
    [No Abstract]   [Full Text] [Related]  

  • 11. [SBU should investigate what is an evidence-based and cost-effective use of statins].
    Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternate-day statin therapy for the treatment of hyperlipidemia.
    Reindl EK; Wright BM; Wargo KA
    Ann Pharmacother; 2010 Sep; 44(9):1459-70. PubMed ID: 20702760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone].
    Eklund K; Grip L; Israelsson B; Levin LA; Lindahl B; Wallentin L
    Lakartidningen; 2008 May 7-13; 105(19):1408-9; discussion 1409. PubMed ID: 18574983
    [No Abstract]   [Full Text] [Related]  

  • 14. [How far the rates of cholesterol have to be lowered in primary prevention?].
    Rodondi N
    Rev Med Suisse; 2010 Mar; 6(239):483-4. PubMed ID: 20373693
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lean years for patients].
    Klose G; Anlauf M
    MMW Fortschr Med; 2004 Dec; 146(51-52):16. PubMed ID: 15675237
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesterol drugs: should you be taking one?
    Consum Rep; 1998 Oct; 63(10):54-5. PubMed ID: 10342966
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States.
    Davies GM; Vyas A; Baxter CA
    J Med Econ; 2017 Jul; 20(7):723-731. PubMed ID: 28426345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of fluvastatin in Hungary following successful percutaneous coronary intervention.
    Scuffham PA; Kósa J
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):309-17. PubMed ID: 16779529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What price atorvastatin?
    Drug Ther Bull; 2012 Jul; 50(7):73. PubMed ID: 22764068
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacoeconomic evaluation of pravastatin in coronary secondary prevention in patients with myocardial infarct or unstable angina pectoris. An analysis based on the LIPID Study].
    Szucs TD; Bertel O; Darioli R; Gutzwiller F; Mordasini R
    Praxis (Bern 1994); 2000 Apr; 89(18):745-52. PubMed ID: 10823012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.